SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001242
Filing Date
2019-09-16
Accepted
2019-09-16 06:08:40
Documents
17
Period of Report
2019-09-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529395_8k.htm   iXBRL 8-K 44012
2 EXHIBIT 23.1 tv529395_ex23-1.htm EX-23.1 1950
3 EXHIBIT 99.1 tv529395_ex99-1.htm EX-99.1 1846558
4 EXHIBIT 99.2 tv529395_ex99-2.htm EX-99.2 1258094
5 EXHIBIT 99.3 tv529395_ex99-3.htm EX-99.3 360409
  Complete submission text file 0001410578-19-001242.txt   4067699

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA abbv-20190916.xsd EX-101.SCH 3550
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20190916_def.xml EX-101.DEF 27930
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20190916_lab.xml EX-101.LAB 36790
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20190916_pre.xml EX-101.PRE 26160
10 EXTRACTED XBRL INSTANCE DOCUMENT tv529395_8k_htm.xml XML 5461
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 191093601
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences